Incidence of treatment for end-stage renal disease among individuals with diabetes in the U.S. continues to decline - PubMed (original) (raw)
Incidence of treatment for end-stage renal disease among individuals with diabetes in the U.S. continues to decline
Nilka Ríos Burrows et al. Diabetes Care. 2010 Jan.
Abstract
Objective: We examined trends in incidence of treatment for diabetes-related end-stage renal disease (ESRD) in the U.S.
Research design and methods: Using the U.S. Renal Data System, we obtained the number of individuals having diabetes listed as primary diagnosis who initiated ESRD treatment between 1990 and 2006. Incidence was calculated using the estimated U.S. population with diabetes from the National Health Interview Survey and then was age adjusted based on the 2000 U.S. standard population. Trends were analyzed using joinpoint regression.
Results: The number of individuals who began diabetes-related ESRD treatment increased from 17,727 in 1990 to 48,215 in 2006. From 1990 to 1996, the age-adjusted diabetes-related ESRD incidence increased somewhat from 299.0 to 343.2 per 100,000 diabetic population (P = 0.45). However, from 1996 to 2006, the age-adjusted diabetes-related ESRD incidence decreased by 3.9% per year (P < 0.01) from 343.2 to 197.7 per 100,000 diabetic population. Among individuals with diabetes aged <45 years, diabetes-related ESRD incidence decreased by 4.3% per year (P < 0.01) from 1990 to 2006. Among older individuals, incidence increased during the 1990s but decreased in later years, by 3.9% per year (P < 0.01) among individuals aged 45-64, by 3.4% per year (P < 0.01) among individuals aged 65-74 years, and by 2.1% per year (P = 0.02) among individuals aged > or =75 years.
Conclusions: Diabetes-related ESRD incidence in the diabetic population has declined in all age-groups, probably because of a reduction in the prevalence of ESRD risk factors, improved treatment and care, and other factors.
Figures
Figure 1
Modeled age-specific incidence of diabetes-related ESRD in the population with diabetes, U.S., 1990–2006. Predicted values: ▲——▲, <45 years; ■——■, 45–64 years; ●——●, 65–74 years; ——, ≥75 years. Predicted values were modeled using joinpoint regression analysis.
Figure 2
Modeled age-adjusted incidence of diabetes-related ESRD in the population with diabetes, by sex and race or ethnicity, U.S., 1990–2006. Predicted values: – – –, women; ●——●, men; ▲——▲, whites; ■——■, blacks; ——, Hispanics. Predicted values were modeled using joinpoint regression analysis. The racial groups include individuals of both Hispanic and non-Hispanic origin; Hispanics may be of any race. NHIS began collecting Hispanic ethnicity data in 1997.
Comment in
- Incidence of treatment for end-stage renal disease among individuals with diabetes in the U.S. continues to decline: response to Burrows, Li, and Geiss.
Villar E, McDonald SP, Couchoud C. Villar E, et al. Diabetes Care. 2010 May;33(5):e69; author reply e70. doi: 10.2337/dc10-0074. Diabetes Care. 2010. PMID: 20427678 No abstract available.
Similar articles
- Incidence of End-Stage Renal Disease Attributed to Diabetes Among Persons with Diagnosed Diabetes - United States and Puerto Rico, 2000-2014.
Burrows NR, Hora I, Geiss LS, Gregg EW, Albright A. Burrows NR, et al. MMWR Morb Mortal Wkly Rep. 2017 Nov 3;66(43):1165-1170. doi: 10.15585/mmwr.mm6643a2. MMWR Morb Mortal Wkly Rep. 2017. PMID: 29095800 Free PMC article. - Incidence of end-stage renal disease attributed to diabetes among persons with diagnosed diabetes --- United States and Puerto Rico, 1996-2007.
Centers for Disease Control and Prevention (CDC). Centers for Disease Control and Prevention (CDC). MMWR Morb Mortal Wkly Rep. 2010 Oct 29;59(42):1361-6. MMWR Morb Mortal Wkly Rep. 2010. PMID: 21030940 - Disproportionately high incidence of diabetes-related end-stage renal disease in the Canary Islands. An analysis based on estimated population at risk.
Lorenzo V, Boronat M, Saavedra P, Rufino M, Maceira B, Novoa FJ, Torres A. Lorenzo V, et al. Nephrol Dial Transplant. 2010 Jul;25(7):2283-8. doi: 10.1093/ndt/gfp761. Epub 2010 Jan 11. Nephrol Dial Transplant. 2010. PMID: 20064954 - Diabetic CKD/ESRD 2010: a progress report?
Williams ME. Williams ME. Semin Dial. 2010 Mar-Apr;23(2):129-33. doi: 10.1111/j.1525-139X.2009.00698.x. Epub 2010 Feb 22. Semin Dial. 2010. PMID: 20210917 Review. - Optimizing end-stage renal disease therapy for the patient with diabetes mellitus.
Friedlander MA, Hricik DE. Friedlander MA, et al. Semin Nephrol. 1997 Jul;17(4):331-45. Semin Nephrol. 1997. PMID: 9241718 Review.
Cited by
- The problem of pulmonary arterial hypertension in end-stage renal disease: can peritoneal dialysis be the solution.
Alhwiesh AK, Abdul-Rahman IS, Alshehri A, Alhwiesh A, Elnokeety M, Essam S, Sakr M, Al-Oudah N, Abdulrahman A, Mohammed AM, Mansour H, El-Salamoni T, Al-Oudah N, Alayoobi L, Aljenaidi H, Al-Harbi A, Mousa D, Abdulnasir A, Skhiri S. Alhwiesh AK, et al. BMC Nephrol. 2022 Dec 5;23(1):386. doi: 10.1186/s12882-022-02998-y. BMC Nephrol. 2022. PMID: 36471276 Free PMC article. - Galectin-1 in Obesity and Type 2 Diabetes.
Fryk E, Silva VRR, Jansson PA. Fryk E, et al. Metabolites. 2022 Sep 30;12(10):930. doi: 10.3390/metabo12100930. Metabolites. 2022. PMID: 36295832 Free PMC article. Review. - Sarcopenia Is an Independent Risk Factor for Severe Diabetic Nephropathy in Type 2 Diabetes: A Long-Term Follow-Up Propensity Score-Matched Diabetes Cohort Study.
Huang YM, Chen WM, Chen M, Shia BC, Wu SY. Huang YM, et al. J Clin Med. 2022 May 25;11(11):2992. doi: 10.3390/jcm11112992. J Clin Med. 2022. PMID: 35683381 Free PMC article. - Obesity and Chronic Kidney Disease in US Adults With Type 1 and Type 2 Diabetes Mellitus.
Wallace AS, Chang AR, Shin JI, Reider J, Echouffo-Tcheugui JB, Grams ME, Selvin E. Wallace AS, et al. J Clin Endocrinol Metab. 2022 Apr 19;107(5):1247-1256. doi: 10.1210/clinem/dgab927. J Clin Endocrinol Metab. 2022. PMID: 35080610 Free PMC article. - Epidemiological characteristics of diabetic kidney disease in Taiwan.
Wang JS, Yen FS, Lin KD, Shin SJ, Hsu YH, Hsu CC; Diabetes Kidney Disease Research Committee of the Diabetes Association of the Republic of China (Taiwan). Wang JS, et al. J Diabetes Investig. 2021 Dec;12(12):2112-2123. doi: 10.1111/jdi.13668. Epub 2021 Oct 3. J Diabetes Investig. 2021. PMID: 34529360 Free PMC article. Review.
References
- United States Renal Data System. USRDS 2008 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States. Bethesda, MD, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2008
- Centers for Disease Control and Prevention. Diabetes data & trends [article online]. Available from http://www.cdc.gov/diabetes/statistics/index.htm Accessed 28 January 2009
- Centers for Disease Control and Prevention. National Diabetes Fact Sheet: General Information and National Estimates on Diabetes in the United States, 2007. Atlanta, GA, U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, 2008
- Burrows NR, Wang J, Geiss LS, Venkat Narayan KM, Engelgau MM: Incidence of end-stage renal disease among persons with diabetes—United States, 1990–2002. MMWR Morb Mortal Wkly Rep 2005; 54: 1097– 1100 - PubMed
- United States Renal Data System. Researcher's Guide to the USRDS Database. Bethesda, MD, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2007